TEIJIN REGENET
Live / Allowed — Fifth extension granted (statement of use) (as of 01 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 May 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98018285
- Mark type
- Word mark
- Filed
- 30 May 2023
- Published for opposition
- 17 Oct 2023
- Attorney of record
- LEIGH ANN LINDQUIST
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals; custom manufacture of cells; custom manufacture of biological tissue cultures; custom manufacture of cell culture medium; custom manufacture of medical apparatus; custom production of structures made of cells; custom processing of cells; consultancy relating to the manufacture of cells; providing information relating to the manufacture of cells; processing of cells used for cell therapy medicine
- Class 042 — Scientific and technological services: Cell culture services for others for scientific and medical research purposes; testing, inspection, research and development of cells and tissue cultures for scientific and medical research purposes; advice, consultancy and providing information relating to testing, inspection, research or development of cells and tissue culture for scientific and medical research purposes; consultancy relating to cell culture and tissue culture for medical research purposes; culture and separation of cells and biological tissue for medical research purposes; consultancy and providing information relating to testing, inspection and research of pharmaceuticals; research and product development of cells; blood analysis services for scientific research purposes; scientific services relating to the isolation and cultivation of human tissues and cells; stem cell research; technological research in the fields of stem cells and tissue culturing; scientific research and development; consultancy and advising relating to culturing of cells
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical consultancy; provision of medical information; advisory, consultancy and information services relating to medical care and regenerative medicine; human tissue bank services; cultured cell bank services for medical transplantation; separation, collection and preservation of blood components for medical purpose
Owner
- Teijin Kabushiki Kaisha (Teijin Limited), Osaka, Tokyo, JP
- Teijin Kabushiki Kaisha (Teijin Limited), Osaka, Tokyo, JP
Prosecution history
- 01 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2026 — SOU EXTENSION 5 GRANTED
- 27 May 2026 — SOU EXTENSION 5 FILED
- 27 May 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 4 GRANTED
- 25 Nov 2025 — SOU EXTENSION 4 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 16 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 May 2025 — SOU EXTENSION 3 GRANTED
- 15 May 2025 — SOU EXTENSION 3 FILED
- 15 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Feb 2025 — SOU EXTENSION 2 GRANTED
- 18 Nov 2024 — SOU EXTENSION 2 FILED